Adverum Biotechnologies Inc (ADVM)

07:25 AM

Adverum Biotechnologies Inc expected to post a loss of $1.36 a shareEarnings Preview - TradingView

07:25 AM

Mar 04, 2025

2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.

Mar 04, 2025

Mar 03, 2025

Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

Adverum launches phase 3 trial for wet AMD gene therapy By Investing.com - Investing.com UK

Mar 03, 2025

Mar 03, 2025

Can This One-Time Gene Therapy Revolutionize Wet AMD Treatment? Adverum's Phase 3 Trial Begins - StockTitan

Mar 03, 2025

Mar 03, 2025

Adverum Biotechnologies initiates ARTEMIS study - TipRanks

Mar 03, 2025

Feb 28, 2025

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 28, 2025

Feb 28, 2025

Adverum biotechnologies sees $1.44 million stock purchase by major shareholder - Investing.com

Feb 28, 2025

Feb 28, 2025

How Adverum is Attracting Talent: New Employees Receive $186,000 in Equity Grants - StockTitan

Feb 28, 2025

Feb 27, 2025

Brokerages Set Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Target Price at $27.83 - MarketBeat

Feb 27, 2025

Feb 25, 2025

Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference - The Manila Times

Feb 25, 2025

Feb 25, 2025

Gene Therapy Developer Adverum to Showcase Ocular Disease Pipeline at Major Healthcare Conference - StockTitan

Feb 25, 2025

Feb 19, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Stock Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat

Feb 19, 2025

Feb 18, 2025

3 US Penny Stocks With Market Caps Below $400M - Yahoo Finance

Feb 18, 2025

Feb 17, 2025

The Sonic Fund Solicits Proxies from Shareholders of Adverum Biotechnologies -April 13, 2021 at 04:16 pm EDT - Marketscreener.com

Feb 17, 2025

Feb 10, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Stock Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Feb 10, 2025

Feb 10, 2025

4D’s new data in wet AMD bolster its phase III study vision - BioWorld Online

Feb 10, 2025

Feb 05, 2025

Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - The Manila Times

Feb 05, 2025

Feb 05, 2025

Gene Therapy Pioneer Adverum Takes Center Stage at Major Healthcare Conference - StockTitan

Feb 05, 2025

Feb 04, 2025

ADVM stock touches 52-week low at $4.01 amid market challenges - MSN

Feb 04, 2025

Feb 02, 2025

Brokerages Set Adverum Biotechnologies, Inc. (NASDAQ:ADVM) PT at $27.83 - MarketBeat

Feb 02, 2025

Feb 02, 2025

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives $27.83 Average PT from Analysts - Defense World

Feb 02, 2025

Jan 21, 2025

Barclays PLC Buys 19,965 Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) - Defense World

Jan 21, 2025

Jan 16, 2025

Comparing Adverum Biotechnologies (NASDAQ:ADVM) & Pluri (NASDAQ:PLUR) - Defense World

Jan 16, 2025

Jan 10, 2025

Adverum Biotechnologies stock hits 52-week low at $4.4 - Investing.com

Jan 10, 2025

Jan 10, 2025

Adverum Biotechnologies stock hits 52-week low at $4.4 By Investing.com - Investing.com South Africa

Jan 10, 2025

Jan 07, 2025

Geode Capital Management LLC Sells 16,731 Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) - Defense World

Jan 07, 2025

Jan 06, 2025

Barclays PLC Purchases 19,965 Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) - Defense World

Jan 06, 2025

Jan 05, 2025

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 05, 2025

Jan 01, 2025

State Street Corp Boosts Stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) - Defense World

Jan 01, 2025

Dec 31, 2024

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Sees Significant Increase in Short Interest - Defense World

Dec 31, 2024

Dec 31, 2024

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Sees Large Increase in Short Interest - MarketBeat

Dec 31, 2024

Dec 23, 2024

Adverum Biotechnologies stock hits 52-week low at $4.61 - Investing.com

Dec 23, 2024

Dec 19, 2024

Adverum Biotechnologies (NASDAQ:ADVM) Cut to Sell at StockNews.com - Defense World

Dec 19, 2024

Dec 19, 2024

StockNews.com Downgrades Adverum Biotechnologies (NASDAQ:ADVM) to Sell - MarketBeat

Dec 19, 2024

Dec 19, 2024

Where are the Opportunities in (ADVM) - Stock Traders Daily

Dec 19, 2024

Dec 16, 2024

Fmr LLC Lowers Stock Holdings in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) - Defense World

Dec 16, 2024

Dec 16, 2024

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Shares Sold by Fmr LLC - MarketBeat

Dec 16, 2024

Dec 16, 2024

Adverum Biotechnologies, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020 - Marketscreener.com

Dec 16, 2024

Dec 15, 2024

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Short Interest Down 11.1% in November - MarketBeat

Dec 15, 2024

Dec 15, 2024

Short Interest in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Drops By 11.1% - Defense World

Dec 15, 2024

Dec 13, 2024

ADVM stock touches 52-week low at $5.61 amid market challenges - Investing.com

Dec 13, 2024

Dec 13, 2024

StockNews.com Upgrades Adverum Biotechnologies (NASDAQ:ADVM) to Hold - Defense World

Dec 13, 2024